19937 results

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review

09 Nov 2021

 

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Author

Alessandro Sticchi

Author

Jonathan Curio

Research, cases and webinars in tricuspid interventions

09 Nov 2021

Brought to you by the PCR Tricuspid Focus Group

The mission of the PCR Tricuspid Focus Group is to facilitate innovation and the development of up-to-date standards of care for patients with tricuspid valve disease, by aligning knowledge, unifying practice and eliminating cultural barriers among physicians and...

Transcatheter tricuspid valve interventions

01 Jul 2025

Several transcatheter tricuspid valve therapies are available to address different targets, including leaflet approximation, annuloplasty, valve replacement, valve-in-valve implantation and heterotopic valve implantation. Such devices and their initial promising evidences are reviewed in this up-to-date chapter!

Authors :

Nicola Buzzatti, Jean-Michel Juliard, Fabien Praz, Alec Vahanian, Azeem Latib, Eric Brochet, Phalla Ou, Dominique Himbert, Mirjam Wild, Domenico Angellotti

Americo Pena

Milan, Italy

GulfPCR-GIM 2021: Course Programme

Updated in real time*, the Course Programme is available in interactive format. Filter sessions according to your need, then obtain more details by clicking on each one.

Peyman Sardari Nia

Maastricht, Netherlands

Abdullah Alsaiedi

Jeddah, Saudi Arabia

Ismail Ismail

Saudi Arabia

Jassim Al Suwaidi

Doha, Qatar

Nouf Alanazi

Riyadh, Saudi Arabia

Fahad Alsindi

Abu Dhabi, United Arab Emirates

Jurij Avramovic

Isola, Slovenia

Jakob Boh

Izola, Slovenia

Sanjaya Kularatne

Colombo, Sri Lanka

Mathews Paul

Kerala, India

Suddharsan Subbramaniyam

Awali, Bahrain

Souad Azougah

Toulouse, France

PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI, ENVISAGE TAVI AF, VKA in patients with AF after TAVI

21 Nov 2021 – From PCR London Valves 2021

In this session, find out more about the JenaValve TAVI system in patients with aortic regurgitation, get results from the GALILEO trial, review a late-breaking on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, and explore the safety and efficacy of edoxaban versus VKA in patients with AF...

State-of-the-art: Transcatheter treatment for tricuspid valve disease

19 Nov 2021

 

The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.

Emergent transcatheter therapy

21 Nov 2021 – From PCR London Valves 2021

This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.